This document provides an overview of acute stroke, including:
1) It defines stroke as a sudden loss of neurological function lasting more than 30 minutes caused by a blockage or rupture of blood vessels in the brain. During a stroke, 2 million brain cells die per minute, making it a medical emergency.
2) It outlines the assessment and workup of acute stroke patients, including using the ROSIER and NIH stroke scales to evaluate severity, performing a CT scan to identify blockages or bleeding, and collecting blood tests.
3) It describes the management of ischemic and hemorrhagic strokes, including the criteria for providing tissue plasminogen activator to dissolve clots or controlling blood pressure to stop
A stroke occurs when the blood supply to part of your brain is interrupted or severely reduced, depriving brain tissue of oxygen and food.
Within minutes, brain cells begin to die.
Stroke can be either ischemic or hemorrhagic.
Acute management of patients with stroke is to stabilize the patient and to complete initial evaluation and assessment, including imaging and laboratory studies, within 60 minutes of patient arrival.
Critical decisions focus on the need for intubation, blood pressure control, and determination of risk/benefit for thrombolytic intervention.
Tom Bleck - Subarachnoid Hemorrhage: What Matters?SMACC Conference
Tom Bleck - Subarachnoid haemorrhage: what matters?
Tom Bleck gives an overview of the pertinent facts regarding the complications and management of aneurysmal subarachnoid haemorrhage (SAH).
The complications of aneurysmal SAH can be divided into immediate, early and late. The risk of re-bleeding is maximal on the first day, it is fatal in 75% of patients and the best management is to secure the aneurysm by coiling or clipping. Blood pressure control is utilised widely but parameters are arbitrary and the data is scarce.
Early complications (days 1 - 3) include early brain injury in its various forms, stress cardiomyopathy, neurogenic pulmonary oedema and cerebral salt wasting. The most important late complication (day 4 onwards) is vasospasm.
Tom briefly discusses the mechanisms and manifestations of SAH-associated brain injury including ischaemia, blood brain barrier breakdown, sustained depolarisation, hydrocephalus, vasospasm, seizures, hyperglycaemia and fever. He goes on to discuss in more detail the management of vasospasm, the associated evidence and the importance of distinguishing between clinically detectable and subclinical vasospasm.
A stroke occurs when the blood supply to part of your brain is interrupted or severely reduced, depriving brain tissue of oxygen and food.
Within minutes, brain cells begin to die.
Stroke can be either ischemic or hemorrhagic.
Acute management of patients with stroke is to stabilize the patient and to complete initial evaluation and assessment, including imaging and laboratory studies, within 60 minutes of patient arrival.
Critical decisions focus on the need for intubation, blood pressure control, and determination of risk/benefit for thrombolytic intervention.
Tom Bleck - Subarachnoid Hemorrhage: What Matters?SMACC Conference
Tom Bleck - Subarachnoid haemorrhage: what matters?
Tom Bleck gives an overview of the pertinent facts regarding the complications and management of aneurysmal subarachnoid haemorrhage (SAH).
The complications of aneurysmal SAH can be divided into immediate, early and late. The risk of re-bleeding is maximal on the first day, it is fatal in 75% of patients and the best management is to secure the aneurysm by coiling or clipping. Blood pressure control is utilised widely but parameters are arbitrary and the data is scarce.
Early complications (days 1 - 3) include early brain injury in its various forms, stress cardiomyopathy, neurogenic pulmonary oedema and cerebral salt wasting. The most important late complication (day 4 onwards) is vasospasm.
Tom briefly discusses the mechanisms and manifestations of SAH-associated brain injury including ischaemia, blood brain barrier breakdown, sustained depolarisation, hydrocephalus, vasospasm, seizures, hyperglycaemia and fever. He goes on to discuss in more detail the management of vasospasm, the associated evidence and the importance of distinguishing between clinically detectable and subclinical vasospasm.
Current management of Spontaneous intracerebral haemorrhage 2016Woralux Phusoongern
Reference : Dastur CK, Yu W. Current management of spontaneous intracerebral haemorrhage. Stroke and Vascular Neurology 2017;00: e000047. doi:10.1136/svn- 2016-000047
Lecture slide on stroke and it's management. Stroke is the term used to describe episodes of focal brain dysfunction due to focal ischaemia or haemorrhage
This is the term reserved for those events in which symptoms last more than 24 hours. Before that we reserve the term as TIA which merits separate discussion.
Current management of Spontaneous intracerebral haemorrhage 2016Woralux Phusoongern
Reference : Dastur CK, Yu W. Current management of spontaneous intracerebral haemorrhage. Stroke and Vascular Neurology 2017;00: e000047. doi:10.1136/svn- 2016-000047
Lecture slide on stroke and it's management. Stroke is the term used to describe episodes of focal brain dysfunction due to focal ischaemia or haemorrhage
This is the term reserved for those events in which symptoms last more than 24 hours. Before that we reserve the term as TIA which merits separate discussion.
an updated account on management of TIA, Ischemic and hemorrhagic stroke in Sri Lanka. This is based on American Stroke Association and NICE guidelines.
We understand the unique challenges pickleball players face and are committed to helping you stay healthy and active. In this presentation, we’ll explore the three most common pickleball injuries and provide strategies for prevention and treatment.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
Immunity to Veterinary parasitic infections power point presentation
Stroke
1. Acute Stroke
Dr Anoja Rajapakse
MBBS,MD,FRCP,FRCPE,FACP,FCCP
Consultant Physician
Geriatric & Stroke Medicine
13th July 2020
2. Definition
• World Health Organization defined stroke as ‘rapidly developed
clinical signs of focal (or global) disturbance of cerebral function,
lasting more than 24 hours or leading to death, with no apparent
cause other than of vascular origin’.
• Sudden focal loss of neurology lasting more than 30 minutes is
considered a stroke and considered for TL
• During acute Stroke, 2 million brains cells die per minute. MEDICAL
EMERGENCY.
6. ROSIER score interpretation
• Blood glucose should be normal
• If the score is 1 or more suggest a stroke
• If the score is 0 or less stroke is unlikely but not excluded
7. History
• Time of onset
• Chronologically what happened
• Drug history – OAC
• Risk factors
• Hypertension
• Diabetes
• High cholesterol
• Smoking
• Atrial fibrillation
• Modified Rankin Score (mRS)
9. NIH Stroke Scale training
• http://www.nihstrokescale.org/
• https://learn.heart.org/lms/activity?@curriculum.id=-
1&@activity.id=2695217&@activity.bundleActivityId=-1
• Do the NIH Stroke Scale in the given order
• Take the first effort
10.
11. INVESTIGATIONS
• Non-contrast CT scan of Brain
• Random Blood Sugar
• Full Blood Count
• Clotting Profile
• ESR
• Renal Function
• Lipid Profile
• HbA1c
• ECG
12. Flow chart for Acute Stroke
Nurse: – Doctor : -
Set of observation* Confirm onset time
Capillary blood sugar Confirm stroke
Insert 18 G Canula Exclude trauma
Blood test ** Request CTB non-cE
¯
Resident Physician/Stroke Physician***
NIHSS
mRS
Stroke checklist
Inform Radiologist
Take patient to CT Scan
¯
Stroke Physician***
Review CTB scan
Review Checklist
Obtain verbal consent
Bolus dose Alteplase
CT angio if indicated with discussion with radiologist
Start Alteplase infusion
Decide on MT
Transfer to ICU/Cathlab
*Observation include Blood pressure, Heart rate, Respiratory rate, Oxygen Saturation, and
ECG monitor
**Blood should include FBC, renal function, Clotting profile, Lipid profile, ESR, HbA1c
***Stroke Physician – any Neurologist, Geriatrician, Internal Medicine Physician maintaining
skill mix to manage Acute Stroke
14. Flow chart for BEL-FAST positive patients
Acute Stroke
CT brain
(Non-Contrast)
st
Ischemic Stroke Haemorrhagic Stroke
Symptoms <4.5 hours
Candidate for TL
Give i.v Alteplase
Admit for management
(ICU/ward)
Candidate for Mechanical Thrombectomy?
CT angiogram aortic arch &above
ASPECTS score >6, NIHSS>6
MT (ICA/M1/M2/BA)
*Control BP
*Stop and reverse OAC
*Refer to Neurosurgeon
Yes
No
Yes
No
Yes
Yes
Transfer to cath lab
15. Acute management of Ischemic Stroke
• Fulfil criteria for TL TL
• If not for TL but suitable for MT CT angiogram refer for MT
• If not for TL or MT.
• Aspirin 300mg stat and daily for 2 weeks. Then Clopidogrel 75mg daily
• PPI cover to reduce gastric erosions
16. Inclusion criteria for TL
• Symptoms of acute stroke on going for at least 30 minutes
• Clear onset time
• Can TL be given within 4.5 hours since the onset of the stroke
• Haemorrhage excluded on CTB
• If the patient has taken warfarin today INR <1.7
• If the patient on DOAC last dose > 24 hours
• NIHSS >5 or disabling speech or vision
17. Exclusion criteria
• Rapidly improving NIHSS
• Stroke or head injury within 3 months
• Major surgery within 14 days
• GI or GU haemorrhage within 21 days
• History of intracranial haemorrhage
• Symptoms suggestive of SAH
• Blood pressure >185/110
• No clotting disorders, thrombocytopenia, IDA
• Hypoglycaemia <3 mmol/l
• No evidence/suspicion of bacterial endocarditis/pericarditis
• Seizure at the onset of stroke
• Child birth within 10 days
• Arterial puncture in a non-compressible site within 7days
• Acute pancreatitis, oesophageal varies, ulcerative GI disease within 3/12, aortic aneurysm, active hepatitis, cirrhosis
19. Alteplase indications
• Acute ischemic stroke within 4.5 hours
• Acute Myocardial infarction
• Pulmonary embolism
• Acute Respiratory Distress Syndrome ???
• Occluded central venous access devices (including those used for
haemodialysis)
20.
21. Dose for acute ischemic stroke
• 0.9mg/kg body weight (max 90mg )
• 10% of the dose given as a intravenous bolus dose over 2 minutes
• 90% of the dose in N/S 100 ml over 1 hour
• During the infusion look for bleeding, allergic reaction, worsening
neurology
22. Observation – post-TL
• NIHSS in 1 hour post-TL
• NIHSS in 24 hours
• NIHSS if clinical deterioration noted
• Observations
• Every 15 minutes for 2 hours
• Every 30 minutes for 6 hours
• Every 60 minutes for 16 hours
23. Observations post-TL
• Why observe so frequently?
• Recognise bleeding from any site – intraabdominal/intracranial
• What to do if deteriorating?
• During thrombolysis any evidence of bleeding stop infusion
• Inform stroke consultant and investigate and recognise the cause of bleeding
• May need haematologist input/neurosurgical input/other experts
• NO INTERVENTIONS for 24hrs – catheters, NG tubes, IM injections
24. Other interventions in ischemic stroke
• NBM until swallow assessed
• Antiplatelets
• After 24 hours for patients who have had TL
• As soon as possible after excluding bleed on the CTB
• Aspirin 300mg orally, Rectally, NG (2 weeks)
• PPI cover to reduce gastric erosions.
• Continue antihypertensives/OHG
• Atorvastatin 80mg noct
• Intermittent Pneumonic Compression stockings for prevention of DVT
29. Haemorrhagic Stroke
• More likely when rapidly deteriorating LOC
• Patients on OAC
• High Blood pressure
30. Haemorrhagic Stroke
• Assess swallow and NG tube if unsafe.
• Reduce Systolic Blood pressure to 130-140 mmHg within 1 hours
• Reverse Oral anticoagulant
• Recombinant Prothrombin Complex (Octoplex)
• Intravenous vitamin K 10 mg stat
• FFP if Octoplex not available
• Refer to neurosurgeon
• Intermittent Pneumonic Compression stocking for DVT prevention
31. feeding
• If swallow safe continue oral feeds and medication
• If swallow unsafe
• Intravenous fluids for 24 hours
• NG tube for nutrition and medication
• Refer to SALT and reassess with therapy
• NG feeds – dietician guided
• Modified diets and fluids